The mycotoxin deoxynivalenol inhibits the cell surface expression of activation markers in human macrophages.
Deoxynivalenol (DON) is the most prevalent trichothecene mycotoxin in crops in Europe and North America. It exhibits several toxic effects including impaired growth and immune dysregulation. Macrophages play pivotal role in the host defense; upon activation, they express several specific cell surface receptors that are important in adhesion and cell signaling. Several studies have demonstrated that DON can affect macrophages, however, very few data are available concerning the effect of DON on human macrophages, and the effect on macrophage cell surface receptors is unknown. In the present study, human blood monocytes, differentiated in vitro into macrophages, were activated with IFN-gamma, in the presence or absence of low concentrations of DON. The expression of CD11c, CD13, CD14, CD18, CD33, CD35, CD54, CD119 and HLA-DP/DQ/DR was analyzed by flow cytometry. As expected, macrophage activation by IFN-gamma upregulated the expression of CD54, CD14, CD119 and HLA-DP/DQ/DR. Incubation with DON decrease the cell surface expression of these activation markers in a dose-dependent manner. When cells were treated with 5muM DON, the mean fluorescence intensity measured for the expression of these receptors was the same as that observed in non-activated macrophages. This inhibitory effect of DON was only observed when the mycotoxin was applied before the activation signal. Taken together, our results suggest that low concentration of DON alter macrophage activation as measured by the expression of cell surface markers. This may have implications for human health when consuming DON contaminated feed.
Waché
Yann J
YJ
INRA, Unité de Pharmacologie-Toxicologie, 180 chemin de Tournefeuille, BP93173, 31931 Toulouse cedex 9, France.
Hbabi-Haddioui
Laila
L
Guzylack-Piriou
Laurence
L
Belkhelfa
Haouaria
H
Roques
Christine
C
Oswald
Isabelle P
IP
D015703:Antigens, CD / Q000187:drug effects* / Q000235:genetics; D002454:Cell Differentiation; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005434:Flow Cytometry; D005453:Fluorescence; D005506:Food Contamination; D005786:Gene Expression Regulation / Q000187:drug effects*; D006681:HLA-D Antigens / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D007371:Interferon-gamma / Q000494:pharmacology; D008264:Macrophages / Q000187:drug effects* / Q000378:metabolism; D009000:Monocytes; D014255:Trichothecenes / Q000008:administration & dosage / Q000633:toxicity*
D015703:Antigens, CD; D006681:HLA-D Antigens; D014255:Trichothecenes; D007371:Interferon-gamma; C007262:deoxynivalenol